Navigation Links
Sterifide Laboratories to Launch 'Powered by SDC' OneShot Plus Disinfectant and Deodorizer
Date:3/2/2009

National Product Launch to Include 24-oz and Convenient 4-oz Travel Size Spray Bottles

SAN DIEGO, March 2 /PRNewswire-FirstCall/ -- PURE Bioscience (Nasdaq: PURE) today announced an agreement with Sterifide Laboratories for the distribution of PURE's silver dihydrogen citrate (SDC)-based disinfectant as OneShot Plus(TM) DD, a new technology in Sterifide Laboratories' OneShot Plus product line. OneShot Plus DD eliminates MRSA and VRE in only 2 minutes.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060119/LATH060LOGO)

Patrick Hurst, Vice President of Operations of Sterifide Laboratories, stated, "We live in a world where various types of organisms causing significant health problems have become resistant to previously effective disinfectants and antibiotics, and we are concerned about the growing threat of resistant pathogens like MRSA and VRE. Until recently, those pathogens were typically confined to hospitals and other closed environments but are now plaguing our communities."

Hurst continued, "That is why we welcomed the opportunity to partner with PURE Bioscience in order to add the SDC-based disinfectant as a powerful weapon against MRSA and VRE to our OneShot Plus line of products. We are first marketing OneShot Plus DD through direct-to-consumer channels, and we plan to launch our 24-oz spray and convenient 4-oz travel size nationwide by April along with the other products in our OneShot line. The marketing program targets both English and Spanish speaking consumers."

Michael L. Krall, President and CEO of PURE Bioscience, commented, "Sterifide will be uniquely positioned as it sells its SDC-based disinfectant through a new market channel. Sterifide's sales and marketing program should further increase awareness and acceptance of SDC as a truly revolutionary disinfectant."

OneShot Plus DD

OneShot Plus DD (currently completing registration in all 50 states) carries remarkable efficacy claims, including a 30-second kill time on standard indicator bacteria, a 24-hour residual kill on standard indicator bacteria, a 2-minute kill time on some resistant strains of bacteria including MRSA and VRE, a 10-minute kill time on fungi, a 30-second kill time on HIV Type I and 3-10-minute kill times on other pathogenic viruses. These claims distinguish the efficacy of OneShot Plus DD from many of the leading commercial and consumer products currently on the market, while maintaining lower toxicity ratings. Based on the EPA toxicity ratings from Category I (high toxicity) down to Category IV, OneShot Plus DD is a Category IV antimicrobial for which precautionary labeling statements are not required. This compares with Category II warning statements for most leading brands of disinfectant products. Each bottle of OneShot Plus DD features PURE's "Powered by SDC" logo.

About Sterifide Laboratories

Founded in 2006 to develop and commercialize specialty, eco-friendly and multipurpose cleaning products as well as disinfectants, Newport Beach, California-based Sterifide Laboratories focuses on launching new products to keep the environment cleaner and healthier. In addition to OneShot Plus DD, the current product line consists of a multi-purpose cleaner/degreaser and a soil remediation cleaner/degreaser. Sterifide Laboratories is dedicated to production of powerful and professional solutions for consumer, commercial and medical cleaning situations. For more information, please visit www.sterifidelabs.com.

About PURE Bioscience

PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA). PURE's proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today's global trend toward industry and consumer use of "green" products while providing competitive advantages in efficacy and safety. Patented SDC is an electrolytically generated source of stabilized ionic silver which formulates well with other compounds. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com.

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

    Sterifide Laboratories Contact:
    Patrick Hurst, Vice President Operations
    Customer.service@sterifidelabs.com

    PURE Investor Contact:
    Paul G. Henning, Vice President
    Cameron Associates
    (212) 245-8800
    paul@cameronassoc.com

    PURE Media Contact:
    Suzanne Matick
    Gutenberg Communications
    (831) 479-1888
    Suzanne@gutenbergpr.com


'/>"/>
SOURCE PURE Bioscience
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
3. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
5. Sandia National Laboratories Selects Allscripts Electronic Health Record and Practice Management for Employee Health Center
6. Andrew Lessmans TWC Construction and ProCaps Laboratories Contract With DT Solar to Install a 700 kW Solar Electric System
7. Mesa Laboratories Names New Vice President of Sales and Marketing
8. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
9. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings
10. Roxane Laboratories, Inc. Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg
11. JDRF partners with Housey Pharmaceutical Research Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... May 26, 2017 , ... via seating is proud ... 24/7 task chair specifically designed for clinical areas. Genie Copper Mesh is a ... with Cupron® to provide customers with a game changing chair that is affordably ...
(Date:5/26/2017)... ... May 26, 2017 , ... After raising nearly $30,000 on Kickstarter ... to be available at a discounted crowdfunding price on Indiegogo . , “Along ... I also wanted to bring a fidget toy to the market that was made ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Silver Birch ... community, which is located on more than four acres of land at 5620 Sohl ... , The 103,000 square-foot building includes 125 studio and one-bedroom apartments. Each of ...
(Date:5/26/2017)... ... 2017 , ... Dr. Alex Rabinovich, a highly-skilled oral surgeon specializing in wisdom ... on insurance options. If a Bay Area patient has to search for a second ... Visiting an in-network provider for a second opinion can ensure a patient receives the ...
(Date:5/26/2017)... ... May 26, 2017 , ... “THE FLINTHILLS FAMILY-Our Journey to the Cross”: the personal journey of ... Cross” is the creation of published authors, Bob and Margaret Massey. Bob Massey is ... is "panther quick and leather tough." His love for others is apparent in all ...
Breaking Medicine News(10 mins):
(Date:5/6/2017)...  May is Stroke Awareness Month and Omron Healthcare ... methods to prevent a stroke: monitor and manage your ... and Prevention, undetected and uncontrolled hypertension is a leading ... leader in personal heart health technology, recently evolved its ... and stroke and is advancing a national public education ...
(Date:5/4/2017)... 4, 2017 Clarius Mobile Health, a ... ultrasound scanners this week at the American Congress ... in San Diego, CA ... is the perfect tool for clinicians to easily ... and evaluate pregnancy-related complications like ectopic pregnancy and ...
(Date:5/4/2017)... May 4, 2017   BioLife Solutions , Inc. ... and marketer of proprietary clinical grade hypothermic storage ... the "Company"), today announced that the Company,s first quarter ... on Thursday, May 11, 2017, and that the Company ... 1:30 p.m. PT that afternoon. Management will provide an ...
Breaking Medicine Technology: